Latest Seahorse Bioscience Inc. Stories
BILLERICA, Mass., June 26, 2012 /PRNewswire/ -- Seahorse Bioscience, the world leader in manufacturing instrumentation and assay kits for measuring cellular metabolism, has announced the launch of its newest product, the XF Palmitate-BSA FAO Reagent, eliminating the need for radioactivity in fatty acid oxidation (FAO) assays. The XF Palmitate-BSA FAO Reagent is a pre-conjugated, quality controlled fatty acid substrate in an aqueous solution that is readily absorbed and utilized by...
NIJMEGEN, Netherlands, May 31, 2012 /PRNewswire/ -- A multi-million euro Marie Curie grant has been awarded to an international consortium including 8 world-leading basic science and clinical centres of excellence, industry leaders Khondrion and Seahorse Bioscience, and a non-profit foundation. The objective of the program titled Mitochondrial European Educational Training (MEET) is to implement training-through-research programs dedicated to unravelling the pathophysiology of...
BILLERICA, Mass., April 25, 2012 /PRNewswire/ -- Seahorse Bioscience, the leader in cellular bioenergetic measurements, announced the launch of its newest stress test kit at the American Association of Cancer Research (AACR) Annual Meeting 2012. The XF Glycolysis Stress Test Kit is the first Standard for measuring glycolytic capacity in cells. Cells rely on two major pathways, mitochondrial respiration and glycolysis, to meet their energy demand. Mitochondrial respiration...
NORTH BILLERICA, Mass., March 2, 2011 /PRNewswire/ -- Seahorse Bioscience, Inc., the leader in the design and development of instruments for assessing cellular bioenergetics, has announced In Vitro Technologies Pty Ltd as the new distributor of Seahorse XF Analyzers and consumables in Australia and New Zealand. Seahorse Extracellular Flux Analyzers provide the first and only kinetic method to measure the two major energy producing pathways - mitochondrial respiration and glycolysis - in...
N. BILLERICA, Mass., Sept. 20 /PRNewswire/ -- Seahorse Bioscience, Inc., the leading manufacturer of instruments and consumables for measuring cellular metabolism announced today that Chief Executive Officer, Jay Teich, will present at the 2010 UBS Global Life Sciences Conference on Tuesday, September 21, 2010 at 4:00 p.m. EDT at the Grand Hyatt Hotel in New York City. Mr. Teich will highlight the company's strategy for maintaining rapid growth of 85% CAGR in a new $1BB Life Science...
N. BILLERICA, Mass., July 16 /PRNewswire/ -- David Ferrick, PhD, Chief Scientific Officer for Seahorse Bioscience, Inc. has been invited to speak at the 16th European Bioenergetics Conference [EBEC] in Warsaw, Poland on July 19, 2010. Dr. Ferrick will describe how investigators are employing the Seahorse XF Analyzer to measure cellular bioenergetics in Alzheimer's and Parkinson's, obesity, diabetes cancer and cardiovascular drug discovery and research. "Today's XF technology is enabling...
N. BILLERICA, Mass., June 16 /PRNewswire/ -- Seahorse Bioscience, Inc., the leader in instruments for assessing cellular bioenergetics, recently organized a symposium on Cancer and Mitochondrial Function featuring Douglas Green, Ph.D., from St. Jude Children's Hospital; Navdeep S. Chandel, Ph.D., from Northwestern Medical School; and Nicholas C. Denko, Ph.D., from Stanford University School of Medicine. The symposium was held June 9th at the Natcher Conference Center in Bethesda, at the...
N. BILLERICA, Mass., Feb. 22 /PRNewswire/ -- Seahorse Bioscience, Inc. today announced it has closed a $5MM financing whose proceeds will be used to fund expansion of domestic and international sales and marketing activities and to increase manufacturing capacity of Seahorse's popular XF series of instruments, the new standard for measuring cell metabolism. Investors in the Series D round included Commonwealth Capital Ventures, FLIR Systems Inc, Rock Maple Ventures, Life Sciences Partners,...
NORTH BILLERICA, Mass., Dec. 29 /PRNewswire/ -- Seahorse Bioscience, Inc., leader in the design and development of instruments for measuring cellular bioenergetics, announced that TheScientist magazine cited their XF96 Extracellular Flux Analyzer as a 2009 Top Ten Innovation. A panel of scientific experts assembled by TheScientist honored the XF Analyzer as the first instrument to measure the two energy pathways of the cell in a microplate, enabling scientists to generate a comprehensive...
NORTH BILLERICA, Mass., Dec. 17 /PRNewswire/ -- Seahorse Bioscience, Inc., the leader in the design and development of instruments for assessing cellular bioenergetics, announced Cell-Bio Biotechnology Co. Ltd as the distributor of Seahorse XF Analyzers and consumables in Taiwan at the 6th Conference of the Asian Society for Mitochondrial Research and Medicine in Taipei. Seahorse Extracellular Flux Analyzers provide the first and only method to measure the two major energy producing...
